Precision Biosciences (DTIL) Retained Earnings (2018 - 2026)
Precision Biosciences (DTIL) reported Retained Earnings of -$546.6 million for Q1 2026, down 8.67% year-over-year from -$598.5 million in Q1 2025, and down 3.49% quarter-over-quarter from -$528.2 million in Q4 2025.
Precision Biosciences (DTIL) Retained Earnings (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Retained Earnings data on file, last reported at -$546.6 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$546.6 million, down 8.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$546.6 million (down 8.67% YoY), and the FY2025 annual result was -$528.2 million, down 9.48% from the prior year.
- Retained Earnings declined to -$546.6 million in Q1 2026 per DTIL's latest filing, from -$528.2 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$344.8 million in Q1 2022 and troughed at -$548.3 million in Q3 2025.
- A 5-year average of -$468.2 million and a median of -$473.3 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings tumbled 35.82% in 2022, then climbed 3.65% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$428.3 million in 2022, then decreased by 14.32% to -$489.6 million in 2023, then rose by 1.46% to -$482.5 million in 2024, then dropped by 9.48% to -$528.2 million in 2025, then retreated by 3.49% to -$546.6 million in 2026.
- Business Quant data shows DTIL's Retained Earnings at -$546.6 million in Q1 2026, -$528.2 million in Q4 2025, and -$548.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - | -546.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -546.63 Mn |
| Dec 31, 2025 | -528.19 Mn |
| Sep 30, 2025 | -548.32 Mn |
| Jun 30, 2025 | -526.55 Mn |
| Mar 31, 2025 | -503.03 Mn |
| Dec 31, 2024 | -482.46 Mn |
| Sep 30, 2024 | -464.72 Mn |
| Jun 30, 2024 | -448.29 Mn |
| Mar 31, 2024 | -481.04 Mn |
| Dec 31, 2023 | -489.63 Mn |
| Sep 30, 2023 | -473.34 Mn |
| Jun 30, 2023 | -465.26 Mn |
| Mar 31, 2023 | -453.37 Mn |
| Dec 31, 2022 | -428.31 Mn |
| Sep 30, 2022 | -399.82 Mn |
| Jun 30, 2022 | -375.88 Mn |
| Mar 31, 2022 | -344.84 Mn |
| Dec 31, 2021 | -316.68 Mn |
| Sep 30, 2021 | -294.39 Mn |
| Jun 30, 2021 | -283.11 Mn |